• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC XTS PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC XTS PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Death (1802)
Event Type  Death  
Manufacturer Narrative
The system was used for treatment.From a device perspective, there was no known device malfunction and no instrument issue was alleged by the presenter.However, since the device could not be ruled out as a possible contributing factor to this event, this case will be reported as a mdr out of an abundance of caution.Since this event is associated with the treatment, this mdr will be against the instrument.The instrument's serial number was not provided in the presentation; therefore, the device history review could not be conducted.Trends were reviewed for complaint categories: death and pulmonary embolism.No trends were detected for these complaint categories.The assessment is based on information available at the time of the investigation.No product was returned for investigation; therefore, it could not be determined if the product met specification based solely on the information provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: death and pulmonary embolism.(b)(4).
 
Event Description
The information for this case came from a german presentation on the use of ecp in patients diagnosed with chronic lung allograft dysfunction (clad) following lung transplantation.The presentation mentioned that 25 out of 252 patients stopped ecp treatment.Two of the 25 patients stopped ecp treatment due to "related" deaths from air embolisms.It is unclear if the "related" deaths were due to the patients' underlying condition or due to their ecp treatment.In a follow-up communication with the presenter could only confirm that one of the deceased patients had been receiving treatment with a therakos device.No product was returned for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XTS PHOTOPHERESIS SYSTEM
Type of Device
XTS PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS, INC
bedminister NJ
Manufacturer (Section G)
THERAKOS, INC.
10 north high street
suite 300
west chester PA 19380
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, NJ 07921
MDR Report Key6749175
MDR Text Key81226595
Report Number2523595-2017-00159
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 07/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/27/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Nurse
Device Model NumberNOT APPLICABLE
Device Catalogue NumberXTS
Device Lot NumberNOT APPLICABLE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received06/27/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death;
-
-